10-year cost-effectiveness analyses of response-based fremanezumab use in migraine patients with inadequate response to prior preventive treatmentsLee Smolen,Stephen Thompson,Timothy Klein,Joshua M. Cohen,Sanjay K. GandhiCEPHALALGIA(2019)引用 0|浏览10暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要